Pfizer/Astellas Take Off On New Xtandi Expansion With EMBARK Data

Astellas Has Said This Kind Of Trial Could Be More Challenging Under IRA

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.